SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-097334
Filing Date
2020-04-03
Accepted
2020-04-03 10:33:10
Documents
15
Period of Report
2020-04-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d911091d8k.htm   iXBRL 8-K 28161
2 EX-99.1 d911091dex991.htm EX-99.1 19763
6 GRAPHIC g911091g0403012604414.jpg GRAPHIC 8004
7 GRAPHIC g911091g0403012626834.jpg GRAPHIC 3016
  Complete submission text file 0001193125-20-097334.txt   196219

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vivo-20200402.xsd EX-101.SCH 3099
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vivo-20200402_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vivo-20200402_pre.xml EX-101.PRE 10972
16 EXTRACTED XBRL INSTANCE DOCUMENT d911091d8k_htm.xml XML 3272
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-14902 | Film No.: 20772091
SIC: 2835 In Vitro & In Vivo Diagnostic Substances